1887
Surveillance and outbreak report Open Access
Like 0

Abstract

In Italy, the incidence of invasive meningococcal disease (IMD) has remained stable since 2007 (around 0.3 cases/100,000 inhabitants). However, as reported for other European countries, an increase of serogroup Y has been observed. In this study we report IMD cases from 2007 to 2013 in Italy and investigate the clinical and epidemiological features of cases affected by serogroup Y. Molecular characteristics of serogroup Y strains are also described. During the study period, the proportion of IMD cases due to serogroup Y increased, ranging from 2% in 2007 to 17% in 2013 (odds ratio (OR): 8.8), whereby the five to 14 years age group was mostly affected (p < 0.001). Overall 81 serogroup Y IMD cases were identified, with a median age of 18 years, ranging from three months to 84 years. Of the 81 respective patient samples, 56 were further subject to molecular typing. The sequence type (ST)-23 complex (clonal complex (cc)23) was predominant among serogroup Y meningococci (54/56 samples), and included nine different STs. Presumably, ST-23 was the founding genotype, with all the other STs presenting as single-locus variants. All cc23 isolates analysed harboured mutations in the gene; however, no associations among mutations, ST and age group were identified. Overall, these findings generate scientific evidence for the use of the quadrivalent meningococcal conjugate vaccine in the five to 14 years age group.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2015.20.45.30061
2015-11-12
2017-11-23
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2015.20.45.30061
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/20/45/eurosurv-20-30061-3.html?itemId=/content/10.2807/1560-7917.ES.2015.20.45.30061&mimeType=html&fmt=ahah

References

  1. Krauland MG, Dunning Hotopp JC, Riley DR, Daugherty SC, Marsh JW, Messonnier NE, et al. Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States. PLoS ONE. 2012;7(4):e35699.  https://doi.org/10.1371/journal.pone.0035699  PMID: 22558202 
  2. Abad R, Agudelo CI, Brandileone MC, Chanto G, Gabastou JM, Hormazabal JC, et al. Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region. J Infect. 2009;59(2):104-14.  https://doi.org/10.1016/j.jinf.2009.06.001  PMID: 19576638 
  3. Agudelo CI, Sanabria OM, Ovalle MV. Serogroup Y meningococcal disease, Colombia. Emerg Infect Dis. 2008;14(6):990-1.  https://doi.org/10.3201/eid1406.071357  PMID: 18507927 
  4. Bröker M, Bukovski S, Culic D, Jacobsson S, Koliou M, Kuusi M, et al. Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012. Hum Vaccin Immunother. 2014;10(6):1725-8.  https://doi.org/10.4161/hv.28206  PMID: 24608912 
  5. Bröker M, Jacobsson S, Kuusi M, Pace D, Simões MJ, Skoczynska A, et al. Meningococcal serogroup Y emergence in Europe: update 2011. Hum Vaccin Immunother. 2012;8(12):1907-11.  https://doi.org/10.4161/hv.21794  PMID: 23032167 
  6. Bröker M, Emonet S, Fazio C, Jacobsson S, Koliou M, Kuusi M, et al. Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013. Hum Vaccin Immunother. 2015;11(9):2281-6.  https://doi.org/10.1080/21645515.2015.1051276  PMID: 26036710 
  7. Vainio A, Toropainen M, Kuusi M, Virolainen A. Characteristics of invasive meningococcal serogroup Y isolates in Finland, 1995-2010. Poster session presented at: 11th European Meningococcal Disease Society (EMGM) meeting; 2011 May 18-20; Ljubljana Slovenia. P037.
  8. Caugant DA, Lovoll Ø, Blystad H. Meningococcal disease in Norway, 2009-2010: emergence of serogroup Y. Poster session presented at: 11th European Meningococcal Disease Society (EMGM) meeting; 2011 May 18-20; Ljubljana Slovenia. P040.
  9. Hedberg ST, Törös B, Fredlund H, Olcén P, Mölling P. Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. Euro Surveill. 2011;16(23):19885. PMID: 21679677 
  10. Fazio C, Neri A, Starnino S, Sofia T, Mastrantonio P, Stefanelli P. Characterization of invasive serogroup Y meningococci in Italy: prevalence of ST-23 Complex/Cluster A3. New Microbiol. 2008;31(4):467-72. PMID: 19123301 
  11. Zhu H, Wang Q, Wen L, Xu J, Shao Z, Chen M, et al. Development of a multiplex PCR assay for detection and genogrouping of Neisseria meningitidis. J Clin Microbiol. 2012;50(1):46-51.  https://doi.org/10.1128/JCM.00918-11  PMID: 22090406 
  12. Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, et al. Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg Infect Dis. 2012;18(1):63-70.  https://doi.org/10.3201/eid1801.110901  PMID: 22261040 
  13. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 2004;186(5):1518-30.  https://doi.org/10.1128/JB.186.5.1518-1530.2004  PMID: 14973027 
  14. Munford RS. Meningococcal infections. In Braunwald E, Hauser SL, Faucim AS, Longo DL, Kasper DL and Jameson JL (ed.). Harrison’s principles of internal medicine. 15th ed., volume 1. Washington DC: McGraw-Hill; 2001;927-30.
  15. Centers for Disease Control and Prevention (CDC). Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996. MMWR Morb Mortal Wkly Rep. 1996;45(46):1010-3. PMID: 8965799 
  16. Racoosin JA, Whitney CG, Conover CS, Diaz PS. Serogroup Y meningococcal disease in Chicago, 1991-1997. JAMA. 1998;280(24):2094-8.  https://doi.org/10.1001/jama.280.24.2094  PMID: 9875877 
  17. du Plessis M, Wolter N, Crowther-Gibson P, Hamstra HJ, Schipper K, Moodley C, et al. Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J Infect. 2014;68(5):455-61.  https://doi.org/10.1016/j.jinf.2013.12.011  PMID: 24393652 
  18. Harrison LH, Shutt KA, Schmink SE, Marsh JW, Harcourt BH, Wang X, et al. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. J Infect Dis. 2010;201(8):1208-24.  https://doi.org/10.1086/651505  PMID: 20199241 
  19. Tsang RS, Henderson AM, Cameron ML, Tyler SD, Tyson S, Law DK, et al. Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada. J Clin Microbiol. 2007;45(6):1753-8.  https://doi.org/10.1128/JCM.02134-06  PMID: 17442798 
  20. Chiou CS, Liao JC, Liao TL, Li CC, Chou CY, Chang HL, et al. Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan. BMC Infect Dis. 2006;6(1):25-32.  https://doi.org/10.1186/1471-2334-6-25  PMID: 16478548 
  21. Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol. 2004;42(11):5146-53.  https://doi.org/10.1128/JCM.42.11.5146-5153.2004  PMID: 15528708 
  22. Claus H, Maiden MCJ, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, et al. Genetic analysis of meningococci carried by children and young adults. J Infect Dis. 2005;191(8):1263-71.  https://doi.org/10.1086/428590  PMID: 15776372 
  23. Van der Ley P, Rodenburg G, Fransen F, Bogaert D, Schipper K, Claus H, et al. Naturally occurring lipid A variants among meningococcal carriage and disease isolates. In: Abstracts of the Seventeenth International Pathogenic Neisseria Conference (IPNC); 2010 Sep 11-16; Banff, Canada; Abstract OM12. Available from: http://neisseria.org/ipnc/history.shtml.
  24. Fransen F, Heckenberg SGB, Hamstra HJ, Feller M, Boog CJP, van Putten JPM, et al. Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog. 2009;5(4):e1000396.  https://doi.org/10.1371/journal.ppat.1000396  PMID: 19390612 
  25. Brouwer MC, Spanjaard L, Prins JM, van der Ley P, van de Beek D, van der Ende A. Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide. J Infect. 2011;62(6):479-83.  https://doi.org/10.1016/j.jinf.2011.03.010  PMID: 21459106 
  26. Persa OD, Jazmati N, Robinson N, Wolke M, Kremer K, Schweer K, et al. A pregnant woman with chronic meningococcaemia from Neisseria meningitidis with lpxL1-mutations. Lancet. 2014;384(9957):1900.  https://doi.org/10.1016/S0140-6736(14)61645-7  PMID: 25457917 
  27. Ladhani SN, Beebeejaun K, Lucidarme J, Campbell H, Gray S, Kaczarski E, et al. Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis.2015;60(4):578-85.  https://doi.org/10.1093/cid/ciu881  PMID: 25389259 
  28. Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 2012;30(Suppl 2):B26-36.  https://doi.org/10.1016/j.vaccine.2011.12.032  PMID: 22178525 
  29. Jolley KA, Maiden MC. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010;11(1):595.  https://doi.org/10.1186/1471-2105-11-595  PMID: 21143983 
/content/10.2807/1560-7917.ES.2015.20.45.30061
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error